Literature DB >> 8252739

Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?

J Földes1, G Tarján, M Szathmari, F Varga, I Krasznai, C Horvath.   

Abstract

OBJECTIVE: The aim of the present study was to elucidate whether endogenous subclinical hyperthyroidism due to a solitary autonomously functioning thyroid nodule affects bone metabolism and is a risk factor for osteoporosis.
DESIGN: In a cross-sectional study measurements of bone mineral density were performed in premenopausal and post-menopausal women. Patients were categorized into non-toxic nodular goitre (n = 32), subclinical hyperthyroid (n = 37) and toxic solitary autonomous thyroid nodule (n = 22) subgroups and the results were compared with those of sex and age-matched control reference population (n = 68). MEASUREMENTS: Lumbar spine and femoral neck bone mineral densities were measured by dual energy X-ray absorptiometry. Single-photon absorptiometry was applied to the measurement of bone mineral content in the midshaft of the radius.
RESULTS: In the non-toxic nodular goitre group, bone densities for all the scanned sites did not differ from the sex and age-matched reference population. At the L2-4 scanning site a significant decrease in the bone mineral density could be observed only in the toxic nodular goitre group and this decrease was more marked in the postmenopausal (P < 0.001) than in the premenopausal females (P < 0.05). At the femoral neck and midshaft radius the mean densitometric values were slightly, but significantly, lower only in the post-menopausal subclinical hyperthyroid group compared with the reference population (P < 0.01). The bone mineral density of the femoral neck, as well as the bone mineral content of the midshaft radius, was significantly decreased in both the premenopausal and post-menopausal patients with a toxic solitary nodule.
CONCLUSION: This study indicates that the bone mineral density of the lumbar spine, femoral neck and the midshaft of the radius are not significantly decreased in premenopausal patients with endogenous subclinical hyperthyroidism resulting from a solitary autonomously functioning thyroid nodule. Conversely, findings hint at the possibility that long-lasting endogenous subclinical hyperthyroidism may be a contributing factor to the development of osteoporosis in some post-menopausal women, mostly at sites where cortical bone preponderates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252739     DOI: 10.1111/j.1365-2265.1993.tb02403.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  17 in total

1.  Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.

Authors: 
Journal:  CMAJ       Date:  1996-10-15       Impact factor: 8.262

2.  Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling.

Authors:  Ramkumarie Baliram; Li Sun; Jay Cao; Jianhua Li; Rauf Latif; Amanda K Huber; Tony Yuen; Harry C Blair; Mone Zaidi; Terry F Davies
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

3.  Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population.

Authors:  K Lee; S Lim; H Park; H Y Woo; Y Chang; E Sung; H S Jung; K E Yun; C W Kim; S Ryu; M J Kwon
Journal:  Osteoporos Int       Date:  2019-11-13       Impact factor: 4.507

4.  Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women.

Authors:  T Saler; S Ahbab; Z A Sağlam; Ş Ö Keşkek; S Kurnaz
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

Review 5.  Thyroid dysfunction in the elderly.

Authors:  Kristien Boelaert
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

6.  Thyroid-stimulating hormone, thyroid hormones, and bone loss.

Authors:  Mone Zaidi; Terry F Davies; Alberta Zallone; Harry C Blair; Jameel Iqbal; Surinder S Moonga; Jeffrey Mechanick; Li Sun
Journal:  Curr Osteoporos Rep       Date:  2009-07       Impact factor: 5.096

Review 7.  Asymptomatic hyperthyroidism in older adults: is it a distinct clinical and laboratory entity?

Authors:  Arshag D Mooradian
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Subclinical thyroid disease.

Authors:  J W Elte; A H Mudde; A C Nieuwenhuijzen Kruseman
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

9.  The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.

Authors:  Bernadette Biondi; Luigi Bartalena; David S Cooper; Laszlo Hegedüs; Peter Laurberg; George J Kahaly
Journal:  Eur Thyroid J       Date:  2015-08-26

10.  Bone demineralization in postmenopausal women: role of anamnestic risk factors.

Authors:  Sandro La Vignera; Rosita A Condorelli; Enzo Vicari; Chiara Nicoletti; Aldo E Calogero
Journal:  Int J Endocrinol       Date:  2012-07-26       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.